Article Sidebar

PDF
Date Published: 12/07/2023
Online Published: 12/07/2023
Abstract Views: 266
Views PDF: 166
DOI: https://doi.org/10.58490/ctump.2023i61.620
Issue
No. 61 (2023): HỘI NGHỊ THƯỜNG NIÊN HỌC VIÊN – SINH VIÊN NGHIÊN CỨU KHOA HỌC NĂM 2023
Section
Article
How to Cite
Khuu , Q. H., Nguyen , T. A., Nguyen , P. N., Tran , T. N. N., Le , T. H., & Phan , T. T. N. (2023). EVALUATION OF REACTIONS AFTER VACCINATION ASTRAZENECA IN FIRST DOSE AND PFIZER IN SECOND DOSE IN CAN THO CITY, 2021. Cantho Journal of Medicine and Pharmacy, 61, 336-342. https://doi.org/10.58490/ctump.2023i61.620

EVALUATION OF REACTIONS AFTER VACCINATION ASTRAZENECA IN FIRST DOSE AND PFIZER IN SECOND DOSE IN CAN THO CITY, 2021

Quang Hiep Khuu 1,, Thuy Anh Nguyen 1, Phuong Nam Nguyen 1, Thi Ngoc Nhung Tran 1, Trung Hieu Le 1, Thi Trung Ngoc Phan 1
1 Can Tho University of Medicine and Pharmacy

Main Article Content

Abstract

Background: vaccination is considered the most effective way to control the COVID-19 pandemic. And the knowlegde on reactions after vaccination and efficacy on Vietnamese people is still limited. Objectives: to determine the prevalence of reactions after vaccination and to evaluate reactions between the matched vaccine group and the mixed vaccine group among workers in Can Tho city, 2021. Marterials and method: a cross-sectional study on 180 subjects working at 2 garment companies in Can Tho city by systematic sampling method. Results: The percentage of reactions after 1st dose vaccine was 72.8% and 2nd dose vaccine was 55.6%, the most common symptom appeared after 1st and 2nd dose injections were fever, chills, headache and fatigue, lethargy. We have found a increase of reactions after vaccination mixed vaccine group to the matched vaccine group (OR = 3.09) and this difference was significant (p = 0.003). Conclusion: the percentage of reactions of COVID-19 vaccine was still high but decrease in 2nd dose. Mixing vaccine was associated with an increase prevalence of reactions. Therefore, that should be considered the benefits and limitations in vaccination against COVID-19.

Article Details

Keywords

Reactions after vaccination, COVID-19, Can Tho

References

1. Ban chỉ đạo quốc gia phòng chống dịch COVID-19. Báo cáo kết quả 02 năm triển khai công tác phòng, chống dịch COVID-19, Hà Nội. 2022.
2. Nguyễn Thanh Hồi và Nguyễn Thị Thu Phương. Bước đầu mô tả nồng độ kháng thể kháng vi rút SARS-CoV-2 sau tiêm vắc xin phòng COVID-19, Tạp chí Y học Việt Nam. 2021. 506(1), 268-272, doi: https://doi.org/10.51298/vmj.v506i1.1219.
3. M. N. Ramasamy and et al. Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial, Lancet. 2021. 396(10267), 1979-1993, doi: 10.1016/s0140-6736(20)32466-1.
4. V. N. Tran and et al. Factors influencing adverse events following immunization with AZD1222 in Vietnamese adults during first half of 2021, Vaccine. 2021. 39(44), 6485-6491, doi: 10.1016/j.vaccine.2021.09.060.
5. D. C. Nguyen and et al. Short-Term Adverse Effects Immediately after the Start of COVID-19 Booster Vaccination in Vietnam, Vaccines (Basel). 2022. 10(8), 1325, doi: 10.3390/vaccines10081325.
6. Y. Solomon and et al. COVID-19 Vaccine: Side Effects After the First Dose of the Oxford AstraZeneca Vaccine Among Health Professionals in Low-Income Country: Ethiopia, J Multidiscip Healthc. 2021. 14, 2577-2585, doi: 10.2147/jmdh.S331140.
7. A. Alhazmi and et al. Evaluation of Side Effects Associated with COVID-19 Vaccines in Saudi Arabia, Vaccines (Basel). 2021. 9(6), 674, doi: 10.3390/vaccines9060674.
8. M. M. Alshahrani và A. Alqahtani. Side Effects of Mixing Vaccines against COVID-19 Infection among Saudi Population, Vaccines (Basel). 2022. 10(4), 519, doi: 10.3390/vaccines10040519.
9. T. T. Nguyen and et al. Reactogenicity and immunogenicity of heterologous prime-boost immunization with COVID-19 vaccine, Biomed Pharmacother. 2022. 147, 112650, doi: 10.1016/j.biopha.2022.112650.
10. R. H. Shaw and et al. Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data, Lancet. 2021 397(10289), 2043-2046, doi: 10.1016/s0140-6736(21)01115-6.